Status:
COMPLETED
Long COVID and Post-exertional Pulmonary Diffusion
Lead Sponsor:
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Conditions:
Long COVID
Breathlessness
Eligibility:
All Genders
Brief Summary
Aim of investigators was to study whether abnormalities of lung diffusing capacity for nitric oxide (DLNO) and carbon monoxide (DLCO) in long COVID may have a clinical impact in relation to exercise i...
Detailed Description
Prolonged recovery from acute coronavirus disease 2019 (long COVID) is characterized in about 30% of subjects from breathlessness and fatigue also during daily activities often associated to decreased...
Eligibility Criteria
Inclusion
- History of dyspnea, fatigue, and exercise intolerance persisting or occurring at least 3 months after the COVID-19 acute phase and lasting ≥2 months.
Exclusion
- History of diseases potentially causing dyspnea or affecting pulmonary gas transport, i.e., bronchial asthma, lung bullous disease, chronic obstructive pulmonary disease, pulmonary interstitial fibrosis or vasculitis, hematological diseases, systemic collagen diseases, congestive heart failure, liver or renal diseases, and morbid obesity.
Key Trial Info
Start Date :
May 24 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 15 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05430503
Start Date
May 24 2022
End Date
June 15 2022
Last Update
June 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Policlinico San Martino IRCCS - S.S. Fisiopatologia Respiratoria
Genoa, Italy, 16132